Marc Delcommenne
MBL International, Des Plaines, USA
Biography
Marc Delcommenne is currently Director of Research and Development at MBL International/MBL Bion. He was an assistant professor at Rush University Medical Center, Chicago where he characterized novel multiple myeloma specific antigens and developed human recombinant antibodies against these targets. He has an expertise in adhesion molecules and studied their regulation by cytokines and the extracellular matrix. He obtained his Ph.D. at the University of Namur, Belgium for the study and characterization of bovine leukocyte integrins.